Home >
Medicine Info >
Nasivion 0.25 mg Nasal Spray
Loading interface...

Nasivion 0.25 mg Nasal Spray

Manufactured byMerck Consumer Healthcare Ltd.
ContainsOxymetazoline
Description
Nasivion 0.25 mg Nasal Spray consists of Oxymetazoline. It is used to treat nasal congestion (stuffy nose) caused by allergies, sinusitis (swelling of the sinus), or the common cold. This medicine works by narrowing the blood vessels in your nasal passages and reducing blood flow. This helps to relieve stuffiness in your nose. Nasivion 0.25 mg Nasal Spray may cause common side effects such as dryness in the nose, temporary irritation or burning sensation, etc. Consult your doctor if these symptoms persist or worsen. Nasivion 0.25 mg Nasal Spray should be administered as directed by your doctor. Avoid using more than the prescribed dose or more often than recommended. Nasivion 0.25 mg Nasal Spray should be avoided if you are allergic to it. Consult your doctor if you have diabetes or heart, thyroid, or prostate problems before beginning treatment with this medicine. Inform your doctor if you are taking other medicines to avoid undesired effects. If you are pregnant or are breastfeeding, consult your doctor before using this medication.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Nasivion 0.25 mg Nasal Spray

  • Irritation of the nose
  • Dry mouth and throat

Uses of Nasivion 0.25 mg Nasal Spray

What is it prescribed for?

  • Nasal congestion
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Nasivion 0.25 mg Nasal Spray starts to show its effect within a few minutes.
  • How long do the effects of this medicine last?
    The effect of Nasivion 0.25 mg Nasal Spray lasts for approximately 12 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Nasivion 0.25 mg Nasal Spray.
  • Can this medicine be taken during pregnancy?
    Due to a lack of safety information, Nasivion 0.25 mg Nasal Spray is not recommended during pregnancy unless necessary. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Nasivion 0.25 mg Nasal Spray passes into breastmilk. Hence this medicine is not recommended during breastfeeding unless necessary. Consult your doctor if you are breastfeeding.

Allergy

Avoid using Nasivion 0.25 mg Nasal Spray if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Monoamine oxidase inhibitors (MAOIs)

Monoamine oxidase inhibitors (MAOIs) are a class of medicines used to treat depression. Nasivion 0.25 mg Nasal Spray is not recommended if you are on treatment with MAOIs or have taken them in the last 14 days due to the increased risk of severe side effects.

Narrow angle glaucoma

Glaucoma is a group of eye conditions in which the optic nerve (the nerve connecting the eye to the brain) is damaged, usually due to high pressure within the eyeballs. Eventually, it may lead to vision loss. Narrow-angle glaucoma occurs due to the blockage of the drainage canals (the structure inside the eye that allows fluid to drain normally from the eye) causing increased pressure inside the eye. Nasivion 0.25 mg Nasal Spray is not recommended for use if you have narrow-angle glaucoma as it may further worsen your condition.

Trans-nasal Transsphenoidal Surgery

Nasivion 0.25 mg Nasal Spray is not recommended for use if you have recently undergone trans-nasal transsphenoidal surgery (surgery to remove the pituitary tumor where the procedure is carried out through the nose). It is also not recommended if you have recently had surgery on your nose or sinuses.
Warnings for special population

Pregnancy

Due to a lack of safety information, Nasivion 0.25 mg Nasal Spray is not recommended during pregnancy unless necessary. Consult your doctor if you are pregnant.

Breast-feeding

It is not known whether Nasivion 0.25 mg Nasal Spray passes into breastmilk. Hence this medicine is not recommended during breastfeeding unless necessary. Consult your doctor if you are breastfeeding.
General warnings

Use in children

Nasivion 0.25 mg Nasal Spray is not recommended for use in children below 12 years of age due to a lack of safety and efficacy studies.

Prolonged use

Prolonged use of Nasivion 0.25 mg Nasal Spray may cause recurrence of your symptoms and worsen your condition. Hence it is not recommended to use this medicine for longer than the prescribed duration.

Other medicines

Nasivion 0.25 mg Nasal Spray may interact with other medicines and cause undesired effects. Inform your doctor about your current medicines, including any herbs or supplements, before using Nasivion 0.25 mg Nasal Spray.

Prostate Enlargement

Prostate enlargement refers to an increase in the size of the prostate gland (the gland located below the urinary bladder in men). The symptoms may include increased urge to urinate, difficulty in urination, inability to completely empty the bladder, etc. Nasivion 0.25 mg Nasal Spray should be used with extreme caution as it may further worsen your condition.

Heart diseases

Nasivion 0.25 mg Nasal Spray should be used with extreme caution if you have pre-existing heart problems due to the increased risk of worsening your condition.

Hyperthyroidism

Hyperthyroidism is a condition that occurs when your thyroid gland (a gland located in your neck) overproduces the thyroid hormone (a chemical substance that regulates metabolism, digestive function, brain development, bone maintenance, etc). The symptoms may include unexpected weight loss, rapid or irregular heartbeat, increased sweating, irritability, etc. Nasivion 0.25 mg Nasal Spray should be used with caution if you have hyperthyroidism due to an increased risk of undesired effects.

Missed Dose

Nasivion 0.25 mg Nasal Spray is usually used on an as-needed basis. However, if you are on a scheduled dosage regimen, administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose to compensate for a missed one.

Overdose

Never use more than the prescribed dose. Consult your doctor in case of an overdose of Nasivion 0.25 mg Nasal Spray.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ergotamine

Beta-2 adrenergic bronchodilators

Duloxetine

Disease interactions

Diabetes

Diabetes is a condition with high blood sugar levels. Prolonged use of Nasivion 0.25 mg Nasal Spray may cause a slight increase in your blood sugar levels. This medicine should be used with caution if you have diabetes.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Administer Nasivion 0.25 mg Nasal Spray as directed by your doctor. Follow the instructions mentioned on the label or the packaging insert. Do not administer more or less than the prescribed dose. Nasivion 0.25 mg Nasal Spray is meant for nasal use only. Do not swallow the medication. Close the cover of the container immediately after use to keep it clean and free from contamination. Do not wipe or rinse the tip of the container. Avoid using Nasivion 0.25 mg Nasal Spray for more than seven days. Consult your doctor if your symptoms do not improve after seven days or if they become worse. Nasivion 0.25 mg Nasal Spray may cause dryness in your mouth and throat. Consume adequate fluids to keep yourself hydrated. Do not share Nasivion 0.25 mg Nasal Spray with others even if their condition appears to be the same as yours.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Nasivion 0.25 mg Nasal Spray belongs to a class of medicines called nasal decongestants. It works by narrowing the blood vessels in your nasal passages and reducing the blood flow, thus providing relief from nasal congestion (stuffy nose).
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Nasal Decongestant, Alpha adrenergic agonists

Schedule

OTC

Medicines.org.uk. 2022. [online] Available at: < [Accessed 23 June 2022].

https://www.medicines.org.uk/emc/files/pil.11520.pdf>

Drugs, H., 2021. Oxymetazoline Nasal Spray: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 22 November 2021].

https://medlineplus.gov/druginfo/meds/a608026.html>

Dailymed.nlm.nih.gov. 2021. Afrin ® Original. [online] Available at: < [Accessed 22 November 2021].

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=89c165ba-3ad5-49b5-a5bb-423dc8e15bad&type=display>

Boots.com. 2022. [online] Available at: < [Accessed 23 June 2022].

https://www.boots.com/wcsstore/ExtendedSitesCatalogAssetStore/Attachment%2FProduct_PatientLeaflets%2F10068168%20-%20Vicks%20Sinex%20MICROMIST%20NASAL%20Spray%2015ml%20PIL.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Jun 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.